Aug 2026· IEEE/ACM International Conference on Connected Health: Applications, Systems and Engineering Technologies· pp. 434-439· 0 citations· 18 references
Abstract
In 2024, approximately 4.1 million Americans turned 65, joining 18% of the current population that is 65+. Our current healthcare system, especially for the elderly, is largely reactive, with treatment often beginning only after symptoms appear and are reported by the patient. This can lead to delays in treatment and poorer outcomes, as patients are often unreliable narrators. While technologies like smartwatches and medical sensors are widely used, they typically function in isolation and provide fragmented information. Furthermore, most AI-based health tools tend to focus on one-size-fits-all models that fail to reflect individual patient differences, treating patients with complex health conditions the same as healthy individuals. This lack of personalization, combined with limited healthcare resources, makes early detection and timely intervention difficult. To address these limitations, this paper presents a vision for Elder Symptoms Individualized Monitoring Systems (E-SIMS), a human-centered reference architecture for proactive elderly health monitoring. The proposed framework integrates multimodal health data, edge intelligence, federated learning, and explainable artificial intelligence to support personalized risk assessment and early intervention workflows. By combining edge-cloud collaboration with clinician-in-the-loop validation and privacy-aware communication mechanisms, E-SIMS aims to enable scalable, trustworthy, and individualized monitoring for aging populations. We outline the conceptual architecture of the system and identify key research challenges that must be addressed to realize this vision in real-world healthcare environments.
Although further refinement is required to improve fall detection, the proposed approach provides a practical foundation for accessible elderly monitoring and has the potential to support caregivers, independent ageing, and community-oriented healthcare.
Suraya Zainuddin, Z. Manap, Nurul Syazwani Muhamad Naszeri et al.· International journal of res...· 0 citations
Neuro AI+ is a socially significant and commercially feasible product addressing a significant void in the management of the Parkinson disease context through the combination of technological innovation and patient-centred care.
Jewel Islam· Journal Of Creative Writing...· 0 citations
An Augmented Reality (AR)-based artificial intelligence (AI) medical companion mobile application named DementiaCare-AR, designed to support dementia patients through real-time conversational interaction, personalised daily routine, and medication reminders, and photo-based cognitive stimulation exercises.
Ahmad Muhammad Anwar, Arman Muhamad Haikal, Ismail Ajune Wanis et al.· EPJ Web of Conferences· 0 citations
Healthcare is generating more continuous, real-time data than ever through sensors, wearable devices, remote patient monitoring and connected care platforms. The opportunity is significant, but collecting data alone does not improve outcomes. Information must be translated into timely, clinically meaningful action with...
Sarah Bell, RN, MSN, MHA, Thomas Osborne, MD, FAIM· Telehealth and Medicine Toda...· 0 citations
Intensified population aging has continuously increased the pressure on community-based chronic disease management, home safety monitoring and mental health services for the elderly. Conventional public health services mainly rely on regular physical examinations and passive follow-up visits, which are plagued by delay...
Lin-Feng Zhang, En-Yu Guo· International Journal of Art...· 0 citations
A one-day summit was hosted in Washington, DC, to explore the future and potential uses of Artificial Intelligence (AI) for older adults and the challenges facing the implementation of this technology into the U.S. health care system.
Peter M. Abadir, Phillip H. C. Phan, M. J. R. Aliberti et al.· Journal of The American Geri...· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.